BRPI0910456A2 - petídeos imunogênicos priônicos e suas repetições - Google Patents
petídeos imunogênicos priônicos e suas repetiçõesInfo
- Publication number
- BRPI0910456A2 BRPI0910456A2 BRPI0910456A BRPI0910456A BRPI0910456A2 BR PI0910456 A2 BRPI0910456 A2 BR PI0910456A2 BR PI0910456 A BRPI0910456 A BR PI0910456A BR PI0910456 A BRPI0910456 A BR PI0910456A BR PI0910456 A2 BRPI0910456 A2 BR PI0910456A2
- Authority
- BR
- Brazil
- Prior art keywords
- petids
- prion
- repetitions
- immunogenic
- prion immunogenic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2872—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12550708P | 2008-04-25 | 2008-04-25 | |
PCT/IB2009/005890 WO2009130612A2 (en) | 2008-04-25 | 2009-04-23 | Prion epitopes and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0910456A2 true BRPI0910456A2 (pt) | 2016-07-19 |
Family
ID=41217203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0910456A BRPI0910456A2 (pt) | 2008-04-25 | 2009-04-23 | petídeos imunogênicos priônicos e suas repetições |
Country Status (6)
Country | Link |
---|---|
US (2) | US9056918B2 (pt) |
EP (1) | EP2279203B1 (pt) |
AU (1) | AU2009239651B2 (pt) |
BR (1) | BRPI0910456A2 (pt) |
CA (1) | CA2721833A1 (pt) |
WO (1) | WO2009130612A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0910456A2 (pt) * | 2008-04-25 | 2016-07-19 | Univ Saskatchewan | petídeos imunogênicos priônicos e suas repetições |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859595A (en) | 1985-05-03 | 1989-08-22 | Strosberg Arthur D | Method for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby |
US4977081A (en) | 1987-05-04 | 1990-12-11 | Adi Diagnostics, Inc. | Stable rabbit-mouse hybridomas and secretion products thereof |
CA2014033C (en) | 1989-04-07 | 1993-02-09 | Stephen D. Acres | Compositions and treatments for pneumonia in animals |
US5422110A (en) | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5723129A (en) | 1991-10-16 | 1998-03-03 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
EP0583980A1 (en) | 1992-08-20 | 1994-02-23 | Eli Lilly And Company | Method for generating monoclonal antibodies from rabbits |
US5675063A (en) | 1995-02-28 | 1997-10-07 | Loyola University Of Chicago | Immortalized rabbit hybridoma fusion partner |
US20030091579A1 (en) * | 1998-05-05 | 2003-05-15 | Jack G. Manns | Methods of raising animals for meat production |
US7041807B1 (en) | 1999-06-23 | 2006-05-09 | Caprion Pharmaceuticals, Inc. | Antibodies to a YYX epitope of a mammalian prion protein |
DE60032486T2 (de) | 1999-06-23 | 2007-08-16 | Idexx Laboratories, Inc. | Prion protein peptide und deren verwendung |
EP1251138B1 (en) * | 2001-04-19 | 2006-07-26 | Hermann Dr. Schätzl | Prion protein dimers useful for vaccination |
WO2003040685A2 (en) | 2001-11-09 | 2003-05-15 | King's College London | Diagnosis demyelinating or spongiform disease |
EP1487875A2 (en) | 2002-03-20 | 2004-12-22 | Health Protection Agency | Antibody that binds to a dimer of a prion protein for the treatment of tse infection |
US20040072236A1 (en) * | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
US20050255525A1 (en) * | 2004-05-13 | 2005-11-17 | Bastian Frank O | Safe method for isolation of prion protein and diagnosis of transmissible spongiform encephalopathies |
US8216788B2 (en) * | 2007-07-20 | 2012-07-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Detection of infectious prion protein by seeded conversion of recombinant prion protein |
BRPI0910456A2 (pt) * | 2008-04-25 | 2016-07-19 | Univ Saskatchewan | petídeos imunogênicos priônicos e suas repetições |
-
2009
- 2009-04-23 BR BRPI0910456A patent/BRPI0910456A2/pt not_active IP Right Cessation
- 2009-04-23 WO PCT/IB2009/005890 patent/WO2009130612A2/en active Application Filing
- 2009-04-23 US US12/386,906 patent/US9056918B2/en not_active Expired - Fee Related
- 2009-04-23 EP EP09735414.6A patent/EP2279203B1/en not_active Not-in-force
- 2009-04-23 CA CA2721833A patent/CA2721833A1/en not_active Abandoned
- 2009-04-23 AU AU2009239651A patent/AU2009239651B2/en not_active Ceased
-
2015
- 2015-05-12 US US14/709,877 patent/US9376476B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2279203B1 (en) | 2016-06-15 |
CA2721833A1 (en) | 2009-10-29 |
WO2009130612A3 (en) | 2010-01-21 |
AU2009239651B2 (en) | 2013-12-12 |
US9056918B2 (en) | 2015-06-16 |
WO2009130612A2 (en) | 2009-10-29 |
EP2279203A4 (en) | 2011-08-31 |
US20150313976A1 (en) | 2015-11-05 |
EP2279203A2 (en) | 2011-02-02 |
AU2009239651A1 (en) | 2009-10-29 |
US9376476B2 (en) | 2016-06-28 |
US20090280125A1 (en) | 2009-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
DK2437790T3 (da) | Konjugeringsfremgangsmåder | |
BRPI0907890A2 (pt) | Implantes lacrimais e métodos relacionados | |
BR112012001260A2 (pt) | conjugados de epsilon-polilisina e o emprego dos mesmos | |
DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
BRPI0918249A2 (pt) | prótese | |
DE112009000964A5 (de) | Tampon | |
BR112012010242A2 (pt) | derivados de heteroarilpiperidina e heteroarilpiperazina | |
SMT201500273B (it) | Diidroetorfine e loro preparazione | |
FR2947556B1 (fr) | Composition polyamide modifiee | |
DE112009003312A5 (de) | Implantat | |
DK2307389T3 (da) | Dibenzothiazepinderivat og anvendelser deraf | |
DK2310037T3 (da) | Conglutin-gamma as-medikament og -kosttilskudpatentkrav | |
BRPI0910456A2 (pt) | petídeos imunogênicos priônicos e suas repetições | |
BRPI0922008A2 (pt) | compostos e respectivos metodos de preparação | |
FR2937843B1 (fr) | Paravent medical | |
DE602009000508D1 (de) | Implantat | |
FI20096360A0 (fi) | Bioliima ja puulevy | |
ES1069883Y (es) | Monolito publicitario | |
DOS2008000043S (es) | Muñequera | |
UA17469S (uk) | Вивіска | |
UA17800S (uk) | Вивіска | |
UA18727S (uk) | Вивіска | |
UA17910S (uk) | Вивіска |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |